Comparative Clinical and Pathomorphological Characteristics of Dupuytren’s Contracture in Men and Women

Cover Page

Abstract

Background. The data available in the literature on the features of the clinical course and functional prognosis of Dupuytren`s disease in women is contradictory, there are no data on comparative pathomorphological studies of palmar fibromatosis in men and women.

The aim of the study was to identify possible differences in the clinical and pathomorphological characteristics of Dupuytren`s disease in men and women.

Materials and Methods. 228 cases of men and 39 women (6:1) who underwent fasciectomy in 2013–2019 period were analyzed. Histomorphometry of paraffin sections of the patient`s palmar fascia specimens of 24 men and 24 women was performed.

Results. Men ranged in age from 26 to 83, the median age is 3 years more in women (p<0.001), but the median age of Dupuytren`s disease debut is 2 years less in women (p<0.001). The frequency of contractures of the 3rd–4th degree was 35.9% in the group of women and 65% in the group of men (p<0.001). In the group of women the frequency of both hands involvement is 15.2% higher, I–III fingers involvement is 8.7% higher, recurrent contracture is 11.1% higher (p<0.1). Histomorphometric analysis of the patient`s palmar fascia specimens showed that women compared to men had 10.23% less adipose tissue (p<0.001), 7.87% less dense connective tissue (p<0.05), but the proportion of hyperplastic connective tissue was 20.31% higher.

Conclusion. Dupuytren`s disease is less common in women, than men. Women seek surgical treatment earlier than men. The tendency to functional limitations intensification and the risk of recurrence in women is associated with higher expression of hyperplastic changes in the fascial structures of the hand.

About the authors

N. A. Shchudlo

Ilizarov National Medical Research Centre for Traumatology and Orthopedics

Email: nshchudlo@mail.ru
ORCID iD: 0000-0001-9914-8563

Natalia A. Shchudlo — Dr. Sci. (Med.), Head of Clinical and Experimental Laboratory of Reconstructive-Plastic Surgery and Hand Surgery

Kurgan

T. A. Stupina

Ilizarov National Medical Research Centre for Traumatology and Orthopedics

Author for correspondence.
Email: StupinaSTA@mail.ru
ORCID iD: 0000-0003-3434-0372

Tatiana A. Stupina — Dr. Sci. (Biol.), Leading Researcher, Laboratory of morphology

Kurgan

Russian Federation

M. M. Shchudlo

Ilizarov National Medical Research Centre for Traumatology and Orthopedics

Email: m.m.sch@mail.ru
ORCID iD: 0000-0003-0661-6685

Mikhail M. Shchudlo — Dr. Sci. (Biol.), Leading Researcher,
Clinical and Experimental Laboratory of Reconstructive-Plastic Surgery and Hand Surgery

Kurgan

D. A. Ostanina

Ilizarov National Medical Research Centre for Traumatology and Orthopedics

Email: ostaninadar@yandex.ru
ORCID iD: 0000-0002-4399-2973

Darya A. Ostanina — PhD Student, Clinic of Reconstructive-Plastic Surgery and Hand Surgery

Kurgan

References

  1. Список литературы
  2. Krassovka J., Borgschulze A., Sahlender B., Lögters T., Windolf J., Grotheer V. Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts. PLoS One. 2019; 14(1):e0209833. doi: 10.1371/journal.pone.0209833.
  3. Staats K.A., Wu T., Gan B.S., O'Gorman D.B., Ophoff R.A. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility. J Dermatol Sci. 2016;83(2):131-7.
  4. doi: 10.1016/j.jdermsci.2016.04.015.
  5. Улищенко А.А., Голубев И.О. Преимущества и недостатки различных методов лечения болезни Дюпюитрена. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2017;2:61-68.
  6. Ulishchenko A.A., Golubev I.O. [Advantages and disadvantages of various methods for Dupuytren’s contracture]. Vestnik travmatologii i ortopedii im. N.N. Priorova [Bulletin of Traumatology and Orthopedics. N.N. Priorov]. 2017;2:61-68. (In Russian).
  7. Шевцов В.И., Исмайлов Г.Р., Козьмина Т.Е., Знаменская М.Г., Данилкин М.Ю. Возможности чрескостного остеосинтеза при лечении больных с приобретенной патологией кисти. Гений Ортопедии. 2002; 8 (1): 19-23.
  8. Shevtsov V.I., Ismailov G.R., Kozmina T.Y., Znamenskaya M.G., Danilkin M.Y. [Transosseous osteosynthesis potentials in treatment of patients withthe hand acquired pathology] Genii ortopedii [Genius of Orthopaedics]. 2002; 8 (1): 19-23. (In Russian).
  9. Salari N., Heydari M., Hassanabadi M., Kazeminia M., Farshchian N., Niaparast M., Solaymaninasab Y., Mohammadi M., Shohaimi S., Daneshkhah A. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2020;15:495. https://doi.org/10.1186/s13018-020-01999-7.
  10. Bogdanov I., Rowland Payne C. Dupuytren contracture as a sign of systemic disease. Clin Dermatol. 2019;37(6):675-678.
  11. doi: 10.1016/j.clindermatol.2019.07.027.
  12. Долганова Т.И., Щудло Н.А., Шабалин Д.А., Костин В.В. Оценка гемодинамики артерий кисти и микроциркуляции кожи при контрактуре Дюпюитрена 3-4 стадий до и после оперативного лечения с применением чрескостной фиксации по Г.А. Илизарову. Гений ортопедии. 2019;25(1):86-92. doi: 10.18019/1028-4427-2019-25-1-86-92.
  13. Dolganova T.I., Shchudlo N.A., Shabalin D.A., Kostin V.V. [Assessment of hemodynamics of the hand arteries and skin microcirculation in Dupuytren's contracture stages 3 to 4 of before and after surgical treatment with the use of Ilizarov transosseous fixation] Genii ortopedii [Genius of Orthopaedics]. 2019;25(1):86-92. (In Russian). doi: 10.18019/1028-4427-2019-25-1-86-92.
  14. Щудло Н.А., Варсегова Т.Н., Ступина Т.А., Щудло М.М. Типы и стадии сосудистого ремоделирования при контрактуре Дюпюитрена (анализ 506 артерий в операционном материале 111 пациентов). Гений ортопедии. 2020;26(2):179-184.
  15. doi: 10.18019/1028-4427-2020-26-2-179-184.
  16. Shchudlo N.A., Varsegova T.N., Stupina T.A., Shchudlo M.M. [Types and stages of vascular remodeling in Dupuytren's contracture (analysis of 506 arteries in the surgical material of 111 patients)] Genii ortopedii [Genius of Orthopaedics]. 2020;26(2):179-184. (In Russian). doi: 10.18019/1028-4427-2020-26-2-179-184.
  17. Murrell G.A., Francis M.J., Howlett C.R. Dupuytren's contracture: Fine structure in relation to aetiology. J Bone Joint Surg Br. 1989;71(3):367-373.
  18. Pagnotta A., Specchia N., Greco F. Androgen receptors in Dupuytren's contracture. J Orthop Res. 2002;20(1):163-8.
  19. doi: 10.1016/S0736-0266(01)00072-9.
  20. Pagnotta A., Specchia N., Soccetti A., Manzotti S., Greco F. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone. J Hand Surg Am. 2003;28(6):1029-34.
  21. doi: 10.1016/s0363-5023(03)00429-5.
  22. Black E.M., Blazar P.E. Dupuytren disease: an evolving understanding of an age-old disease. J Am Acad Orthop Surg. 2011;19(12):746-57.
  23. doi: 10.5435/00124635-201112000-00005.
  24. Anthony S.G., Lozano-Calderon S.A., Simmons B.P., Jupiter J.B. Gender ratio of Dupuytren's disease in the modern U.S. population. Hand (N Y). 2008;3(2):87-90. doi: 10.1007/s11552-007-9076.
  25. Stahl S., Calif E. Dupuytren's palmar contracture in women. Isr Med Assoc J. 2008;10(6):445-447.
  26. Ferry N., Lasserre G., .Pauchot J., Lepage D., Tropet Y. Particularités de la maladie de Dupuytren chez la femme. À propos de 67 cas. Ann Chir Plast Esthet. 2013;58:663-669.
  27. https://doi.org/10.1016/j.anplas.2012.08.001
  28. Wilbrand S., Ekbom A., Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br. 1999;24(4):456-459. doi: 10.1054/jhsb.1999.0154.
  29. Balaguer T., David S., Ihrai T., Cardot N., Daideri G., Lebreton E. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur Vol. 2009;34(4):493-6.
  30. doi: 10.1177/1753193409103729.
  31. Tubiana R. Dupuytren’s disease of the radial side of the hand. Hand Clin. 1999;15(1):149-159.
  32. Warren R.F. The pathology of Dupuytren’s contracture. Br J Plast Surg. 1953;6(3):224-230.
  33. Anwar M.U., Al Ghazal S.K., Boome R.S. Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients. J Hand Surg Am. 2007;32(9):1423-8. doi: 10.1016/j.jhsa.2007.06.015.
  34. Mikkelsen O.A. Dupuytren's disease-initial symptoms, age of onset and spontaneous course. Hand. 1977;9(1):11-5.
  35. doi: 10.1016/s0072-968x(77)80023-5.
  36. Di C.M., Bentham J., Stevens G.A., Zhou B., Danaei G., Lu Y., Bixby H., Cowan M.J., Riley L.M., Hajifathalian K. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 populationbased measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377.
  37. http://dx.doi.org/10.1016/S0140-6736(16)30054-X.
  38. Abe Y., Rokkaku T., Ofuchi S., Tokunaga S., Takahashi K., Moriya H. Dupuytren's disease on the radial aspect of the hand: report on 135 hands in Japanese patients. J Hand Surg Br. 2004;29:359-62.
  39. doi: 10.1016/j.jhsb.2003.12.007.
  40. Hueston J.T. Dupuytren's contracture: the trend to conservatism. Ann R Coll Surg Engl. 1965;36(3):134-51.
  41. Forsman M., Kallioinen L., Kallioinen M., Ryhänen J. Dupuytren's contracture; increased cellularity--proliferation, is there equality? Scand J Surg. 2005;94(1):71-5.
  42. doi: 10.1177/145749690509400117.
  43. Rombouts J.J., Noel H., Legrain Y., Munting E. Prediction of recurrence in the treatment of Dupuytrena’s disease: evaluation of a histologic classification. J Hand Surg Am. 1989;14: 644-52.
  44. doi: 10.1016/0363-5023(89)90183-4.
  45. Balaguer T., David S., Ihrai T., Cardot N., Daideri G., Lebreton E. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur Vol. 2009;34(4):493-6.
  46. doi: 10.1177/1753193408103729.
  47. Balık M.S, Bedir R., Palmar Fibromatosis: An Analysis of 25 Cases. Eur Arch Med Res. 2019; 35. (1):43-48.
  48. doi: 10.4274/eamr.galenos.2018.09719.
  49. Johnson B.Z., Stevenson A.W., Prêle C.M., Fear M.W., Wood F.M. The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing. Biomedicines. 2020; 8(5):101. doi: 10.3390/biomedicines8050101.
  50. Milan-Mattos J.C., Anibal F.F., Perseguini N.M., Minatel V., Rehder-Santos P., Castro C.A., Vasilceac F.A., Mattiello S.M., Faccioli L.H., Catai A.M. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9):e8392.
  51. doi: 10.1590/1414-431X20198392.
  52. Abshirini M., Siassi F., Koohdani F., Qorbani M., Mozaffari H., Aslani Z., Soleymani M., Entezarian M., Sotoudeh G. Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women: a cross-sectional study. Ann Gen Psychiatry 2019;18:3.
  53. https://doi.org/10.1186/s12991-019-0225-7.

Supplementary files

There are no supplementary files to display.

Statistics

Views

Abstract: 179

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies